Riskpilot← Back to searchSign inGet full accessDoctronica Oy
OYActiveY-tunnus 2840698-5Pl 15Medical specialists activities · NACE 8622Est. 201731 employees
Revenue 2025
EUR 146K
+46% vs 2023
EBITDA margin
-0.1%
-100% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2025
EUR 72
+101% vs 2023
| Revenue | EUR 146K | +46% |
| EBITDA | EUR -113 | -100% |
| Net profit | EUR 72 | +101% |
| Total assets | EUR 57K | -44% |
| Equity | EUR 57K | -44% |
| Employees | 31 | — |
Legal name
Doctronica Oy
Y-tunnus number
2840698-5
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
20. kesäkuuta 2017
Share capital
EUR 2 500
Employees
31 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on tuottaa terveyden- ja sairaudenhoitopalveluja.
Yhtiö voi tuottaa myös alan tutkimus-, koulutus-,ICT-, luento- ja konsultointipalveluja.
Yhtiö voi omistaa, hallita ja vuokrata asunto- ja kiinteistöyhtiöiden osakkeita sekä käydä arvopaperikauppaa.
Address
Pl 15
Email
doctronicapalvelut@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|
| Revenue | 161 | 127 | 152 | 100 | 146 |
| Staff expenses | −72 | −52 | −59 | −25 | −96 |
| EBITDA | 52 | 44 | 55 | 48 | −0 |
| Depreciation & amort. | — | — | −1 | −1 | −0 |
| EBIT | 52 | 44 | 54 | 47 | −1 |
| Net financials | 2 | 1 | 2 | −53 | 1 |
| Profit before tax | 54 | 45 | 56 | −6 | 0 |
| Tax | 9 | 9 | 11 | 0 | −0 |
| Net profit | 45 | 36 | 45 | −6 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|
| Total assets | 53 | 82 | 119 | 103 | 57 |
| Equity | 48 | 80 | 118 | 103 | 57 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 5 | 2 | 0 | 0 | 0 |
| Total debt | 5 | 2 | 0 | 0 | 0 |
EBITDA margin
-0.1%
This company
15.8%
Market median
-101% vs market
20202025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202025
Return on equity
0.1%
This company
18.4%
Market median
-99% vs market
20202025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202025
Asset turnover
2.54×
This company
1.12×
Market median
+127% vs market
20202025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LS Chief Executive Officer | Chief Executive Officer | 2017 |
TH Deputy Member | Deputy Member | 2017 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doctronica Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lauri Samuli Tuomisto | Chief Executive Officer | 0 companies |
| Timo Harri Juhani Tuomisto | Deputy Member | 0 companies |